United Medipharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.80 M
- Company Age 24 Year, 10 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 2.40 Cr
- Satisfied Charges ₹ 7.50 M
About United Medipharma
United Medipharma Private Limited (UMPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 April 2000 and has a history of 24 years and ten months. Its registered office is in Jaipur, Rajasthan.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.80 M.
The company currently has active open charges totaling ₹2.40 Cr. The company has closed loans amounting to ₹7.50 M, as per Ministry of Corporate Affairs (MCA) records.
Usha Mittal, Himanshu Mittal, Hem Kasana, and One other member serve as directors at the Company.
Company Details
- Location Jaipur, Rajasthan
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232RJ2000PTC016280
-
Company No.
016280
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Apr 2000
-
Date of AGM
30 Sep 2014
-
Date of Balance Sheet
31 Mar 2014
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at United Medipharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Usha Mittal
|
Additional Director | 19-May-2014 | Current |
|
Himanshu Mittal
|
Director | 28-May-2012 | Current |
|
Hem Kasana
|
Additional Director | 27-Feb-2015 | Current |
|
Rohit Gour
|
Additional Director | 27-Feb-2015 | Current |
Financial Performance of United Medipharma.
Enhance accessibility to United Medipharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of United Medipharma?
Unlock access to United Medipharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹24.00 M
₹7.50 M
Charges Breakdown by Lending Institutions
- Uco Bank : 2.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Apr 2013 | Uco Bank | ₹1.70 Cr | Open |
| 29 Mar 2008 | Uco Bank | ₹5.00 M | Open |
| 18 Dec 2001 | Uco Bank | ₹2.00 M | Open |
| 18 Oct 2011 | Hdfc Bank Limited | ₹7.50 M | Satisfied |
How Many Employees Work at United Medipharma?
Unlock and access historical data on people associated with United Medipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of United Medipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped United Medipharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
